Man Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-68,657
| Closed | -$5.02M | – | 2011 |
|
|
2024
Q1 | $5.02M | Sell |
68,657
-75,780
| -52% | -$5.54M | 0.01% | 924 |
|
|
2023
Q4 | $10.3M | Buy |
+144,437
| New | +$10.3M | 0.03% | 614 |
|
|
2023
Q3 | – | Sell |
-146,160
| Closed | -$10.5M | – | 670 |
|
|
2023
Q2 | $10.5M | Buy |
+146,160
| New | +$10.5M | 0.03% | 608 |
|
|
2023
Q1 | – | Sell |
-113,079
| Closed | -$7.55M | – | 547 |
|
|
2022
Q4 | $7.55M | Sell |
113,079
-50,106
| -31% | -$3.35M | 0.03% | 681 |
|
|
2022
Q3 | $8.77M | Buy |
+163,185
| New | +$8.77M | 0.04% | 513 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 777 |
|
|
2021
Q2 | – | Sell |
-5,359
| Closed | -$510K | – | 1948 |
|
|
2021
Q1 | $510K | Sell |
5,359
-95,414
| -95% | -$9.08M | ﹤0.01% | 1471 |
|
|
2020
Q4 | $6.25M | Sell |
100,773
-85,734
| -46% | -$5.32M | 0.03% | 673 |
|
|
2020
Q3 | $11.1M | Buy |
186,507
+117,613
| +171% | +$6.99M | 0.04% | 431 |
|
|
2020
Q2 | $4.81M | Buy |
68,894
+12,962
| +23% | +$904K | 0.02% | 684 |
|
|
2020
Q1 | $2.54M | Sell |
55,932
-201,906
| -78% | -$9.16M | 0.02% | 793 |
|
|
2019
Q4 | $16.8M | Buy |
257,838
+90,727
| +54% | +$5.9M | 0.06% | 423 |
|
|
2019
Q3 | $10.4M | Sell |
167,111
-14,422
| -8% | -$896K | 0.04% | 570 |
|
|
2019
Q2 | $12.9M | Buy |
181,533
+115,243
| +174% | +$8.21M | 0.05% | 514 |
|
|
2019
Q1 | $5.2M | Sell |
66,290
-46,532
| -41% | -$3.65M | 0.02% | 891 |
|
|
2018
Q4 | $9.55M | Sell |
112,822
-8,592
| -7% | -$727K | 0.04% | 465 |
|
|
2018
Q3 | $20.8M | Sell |
121,414
-70,799
| -37% | -$12.1M | 0.08% | 301 |
|
|
2018
Q2 | $24.8M | Sell |
192,213
-71,000
| -27% | -$9.18M | 0.1% | 201 |
|
|
2018
Q1 | $27.1M | Buy |
+263,213
| New | +$27.1M | 0.12% | 164 |
|